Natriuretic Peptides Are Neuroprotective on In Vitro Models of PD and Promote Dopaminergic Differentiation of hiPSCs-Derived Neurons via the Wnt/β-Catenin Signaling

Scientists reported that atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide accelerated the dopaminergic differentiation of human induced pluripotent stem cells (hiPSCs)-derived neural population, making these attractive molecules for both neuroprotection and neurorepair in Parkinson’s disease (PD).